A Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk (HERCEPTIN HYLECTA) or pertuzumab trastuzumab and hyaluronidase-zzfx (PHESGO) in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcom Read more
Quantification and purification of circulating exosomes as a diagnostic tool for bladder cancer detection Read more
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response Read more
WATER IV Prostate Cancer: Aquablation versus Radical Prostatectomy for the Treatment of Localized Prostate Cancer Read more
A Randomised, Double-blind, Placebo-controlled, Phase III Study of Adjuvant Saruparib (AZD5305) in Patients with BRCAm Localised High-Risk Prostate Cancer Receiving Radiotherapy with Androgen Deprivation Therapy (EvoPAR-Prostate02) Read more
A Prospective Observational Protocol to Evaluate Clinical and Functional Outcomes After Focal Therapy in Patients with Prostate Cancer Read more
Integrating Cell-Free DNA Molecular Profiles with Clinical Metadata to Inform Early-Stage Colorectal and Breast Cancer Outcomes Read more
